Daniel A. de Boer is a Dutch serial entrepreneur and has acted as the founding Chief Executive Officer of ProQR Therapeutics since the company’s incorporation in 2012. When Daniel’s newborn son was diagnosed with a rare genetic disease, he decided to start ProQR to develop drugs that could address this. Prior to founding ProQR, Daniel was the founder and CEO of several IT companies, including RNA Systems, PC Basic and Running IT, that he led through several phases of growth. Daniel is also co-founder and advisor to the CEO at Amylon Therapeutics
.svg)
